| ClinicalTrials.gov: nano | Last update posted in the last 14 days |
|---|
| Hybrid Ceramic on Worn Dentition Patients |
| Mon, 01 Mar 2021 12:00:00 EST Condition: Dental Wear Intervention: Procedure: Hybrid composite nano-ceramic Sponsors: National Taiwan University Hospital; Taipei Medical University Hospital Recruiting |
| Use of Perforated Barrier Membranes and IPRF Nano- Micro Sticky Bone |
| Mon, 01 Mar 2021 12:00:00 EST Condition: Bone Augmentation Interventions: Procedure: Perforated collagen membrane; Procedure: Occlusive collagen membrane Sponsor: Ain Shams University Completed |
| Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection |
| Wed, 10 Feb 2021 12:00:00 EST Condition: SARS-CoV-2 Intervention: Drug: EXO-CD24 Sponsor: Tel-Aviv Sourasky Medical Center Recruiting |
| Pharmacokinetics and Metabolism of 14 Carbon [14C]-GSK3640254 |
| Tue, 11 Aug 2020 12:00:00 EDT Condition: HIV Infections Interventions: Drug: GSK3640254 Oral tablet; Drug: [14C]-GSK3640254 intravenous infusion; Drug: [14C]-GSK3640254 powder Sponsor: ViiV Healthcare Completed |
| Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM |
| Wed, 15 Jul 2020 12:00:00 EDT Condition: Glioblastoma Multiforme Intervention: Device: Optune® Sponsor: NovoCure GmbH Recruiting |
| Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma |
| Thu, 14 May 2020 12:00:00 EDT Conditions: Recurrent Malignant Glioma; Brain Glioblastoma Interventions: Drug: OKN-007; Drug: Temozolomide (TMZ) Sponsor: Oblato, Inc. Recruiting |
| Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity |
| Fri, 24 Apr 2020 12:00:00 EDT Conditions: Rotator Cuff Tears; Rotator Cuff Injuries; Rotator Cuff Syndrome of Shoulder and Allied Disorders Interventions: Device: Rotium nanoscaffold; Procedure: Control arm rotator cuff repair Sponsors: Joshua Szabo, MD; Atreon Orthopedics Not yet recruiting |
| Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients |
| Thu, 10 Oct 2019 12:00:00 EDT Condition: Glioblastoma Interventions: Drug: Olaptesed pegol; Radiation: Radiotherapy Sponsor: NOXXON Pharma AG Recruiting |
| A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients |
| Fri, 04 Oct 2019 12:00:00 EDT Condition: Glioblastoma Multiforme Interventions: Drug: Valganciclovir Tablets; Drug: Temozolomide 120 mg; Radiation: Radiotherapy 60 Gy; Drug: Placebo oral tablet Sponsors: Cecilia Soderberg-Naucler; Karolinska University Hospital; Karolinska Institutet Recruiting |
| CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis |
| Mon, 14 Dec 2015 12:00:00 EST Condition: Candidiasis, Chronic Mucocutaneous Intervention: Drug: Amphotericin B Sponsor: Matinas BioPharma Nanotechnologies, Inc. Active, not recruiting |
| A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function |
| Wed, 13 May 2015 12:00:00 EDT Conditions: Diabetes; Diabetes Mellitus, Type 1 Interventions: Drug: NNC0114-0006; Drug: liraglutide; Drug: placebo Sponsor: Novo Nordisk A/S Completed |
| Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma |
| Mon, 12 Jan 2015 12:00:00 EST Condition: Glioblastoma Interventions: Drug: Durvalumab; Radiation: Standard radiotherapy; Biological: Bevacizumab Sponsors: Ludwig Institute for Cancer Research; MedImmune LLC; Cancer Research Institute, New York City; Cure Brain Cancer Foundation, Australia Active, not recruiting |